Oosting, Sjoukje Fvan der Veldt, Astrid A MFehrmann, Rudolf S NGeurtsvanKessel, Corine Hvan Binnendijk, Rob SDingemans, Anne-Marie CSmit, Egbert FHiltermann, T Jeroen Nden Hartog, GercoJalving, MathildaWestphal, Tatjana TBhattacharya, Arkajyotide Wilt, FayeBoerma, Annemarievan Zijl, LisanneRimmelzwaan, Guus FKvistborg, Piavan Els, Cecile A C MRots, Nynke Yvan Baarle, DebbieHaanen, John B A Gde Vries, Elisabeth G E2022-05-042022-05-042022-04-253548338310.1016/S1470-2045(22)00203-0http://hdl.handle.net/10029/625751enImmunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours.Article1474-5488The Lancet. Oncology 2022; 23(7):833-835